REMOVING QUALITY ROADBLOCKS FOR CELL & GENE THERAPIES
Keith Lamb, Executive Director, Lachman Consultant Services, Inc., will be joined by a panel of Cell & Gene Therapy (CGT) industry experts from leading organizations as they discuss the key considerations of successful CGT manufacturing and quality strategies.
Roundtable topics will include:
• Developing a successful regulatory strategy in the evolving CGT field
• Achieving CGT quality and compliance through effective quality systems implementation
• Navigating increasing CGT manufacturing demand and capacity and scalability challenge
• Avoiding quality and compliance issues to ensure patient access
Gain insights, actionable information, and successful strategies in overcoming obstacles in CGT manufacturing and quality.
SECURE YOUR SPOT TODAY!
